These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 23369094

  • 1. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
    Md S, Ali M, Baboota S, Sahni JK, Bhatnagar A, Ali J.
    Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
    [Abstract] [Full Text] [Related]

  • 2. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F.
    J Control Release; 2012 Jan 10; 157(1):149-59. PubMed ID: 21864595
    [Abstract] [Full Text] [Related]

  • 3. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB, Surana SJ.
    J Biomater Sci Polym Ed; 2013 Jan 10; 24(15):1740-56. PubMed ID: 23705812
    [Abstract] [Full Text] [Related]

  • 4. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
    Italia JL, Bhatt DK, Bhardwaj V, Tikoo K, Kumar MN.
    J Control Release; 2007 Jun 04; 119(2):197-206. PubMed ID: 17399839
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.
    Seju U, Kumar A, Sawant KK.
    Acta Biomater; 2011 Dec 04; 7(12):4169-76. PubMed ID: 21839863
    [Abstract] [Full Text] [Related]

  • 6. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP, Desai JL, Thakkar HP.
    J Pharm Pharmacol; 2015 Oct 04; 67(10):1337-48. PubMed ID: 25944126
    [Abstract] [Full Text] [Related]

  • 7. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S, Sowmya S, Cinu TA, Aleykutty NA, Thomas S, Souto EB.
    Eur J Pharm Sci; 2014 Oct 15; 63():29-35. PubMed ID: 25010261
    [Abstract] [Full Text] [Related]

  • 8. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, Schäller S, Bakowsky U, Kissel T.
    J Control Release; 2007 May 14; 119(1):41-51. PubMed ID: 17346845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A, Vishwanatha JK.
    Anticancer Res; 2009 Oct 14; 29(10):3867-75. PubMed ID: 19846921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
    Simon LC, Sabliov CM.
    Drug Metab Rev; 2014 May 14; 46(2):128-41. PubMed ID: 24303927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.